Survey of cannabis use in patients
with amyotrophic lateral sclerosis
by
Amtmann D, Weydt P, Johnson KL, Jensen MP, Carter GT.
Department of Rehabilitation Medicine,
University of Washington School of Medicine,
Seattle, Washington, USA.
Am J Hosp Palliat Care. 2004 Mar-Apr;21(2):95-104
ABSTRACTCannabis (marijuana) has been proposed as treatment for a widening spectrum of medical conditions and has many properties that may be applicable to the management of amyotrophic lateral sclerosis (ALS). This study is the first, anonymous survey of persons with ALS regarding the use of cannabis. There were 131 respondents, 13 of whom reported using cannabis in the last 12 months. Although the small number of people with ALS that reported using cannabis limits the interpretation of the survey findings, the results indicate that cannabis may be moderately effective at reducing symptoms of appetite loss, depression, pain, spasticity, and drooling. Cannabis was reported ineffective in reducing difficulties with speech and swallowing, and sexual dysfunction. The longest relief was reported for depression (approximately two to three hours).Bliss
Memory
Hemp oil
Anandamide
Cannabis: effects
Forgetful rodents
Stoned chocaholics?
The nectar of delight
Cannabis and schizophrenia
Cannabinoids/Parkinson's disease01 02 03 04 05 06 07 08 09 10 11 12 13 14 15
Refs
HedWeb
Future Opioids
BLTC Research
Paradise-Engineering
Utopian Pharmacology
The Hedonistic Imperative
When Is It Best To Take Crack Cocaine?
The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family
